Ultrasound radiomics and deep learning for predicting antral follicle count and anti-Müllerian hormone

超声放射组学和深度学习在预测窦卵泡计数和抗苗勒氏管激素方面的应用

阅读:2

Abstract

To overcome inter-observer variability in conventional antral follicle count (AFC) assessment and AMH testing limitations, we developed an AI-powered framework using routine 2D ultrasound to standardize ovarian-reserve evaluation in assisted reproductive technology (ART). This multicenter retrospective study analyzed 395 women with infertility from two affiliated hospitals. The cohort was divided into training (n = 210), internal-test (n = 91), and external-test (n = 94) cohorts. We established three prediction models: radiomics model, 674 IBSI-compliant features; deep-learning model, ResNet50-based feature extraction; fusion model, hybrid approach combining both modalities. Model performance was validated against the manual AFC and serum AMH levels. Sequential classification categorized patients into low, moderate, or high ovarian-response risk groups. Strong correlation and consistency existed between routine 2D ultrasound image AFCs and three-dimensional dynamic-scan AFCs. The deep learning-radiomics fusion model displayed superior AFC prediction (R²=0.743 internal/0.583 external), surpassing the performance of single-modality models (radiomics: 0.586/0.572; deep learning: 0.737/0.541). For AMH prediction, the fusion model maintained generalizability (external R²=0.509 vs. 0.420 radiomics and 0.352 deep learning, p < 0.05). In ovarian-response stratification, the fusion model achieved an AUC of 0.881 (95%CI: 0.828-0.925), which was 8.0% higher than that of individual models, with 69.1% sensitivity and 84.6% specificity for identifying high-risk patients requiring stimulation-protocol modifications. The developed AI framework enables standardized ovarian-reserve evaluation using routine 2D ultrasound, effectively bridging imaging limitations by synergizing radiomics and deep learning. Meanwhile, the model achieves clinical applicability by enabling personalized ovarian-stimulation protocol optimization, demonstrating particular value in resource-limited clinical environments without requiring advanced imaging infrastructure.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。